Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 2/20 | 0.38 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 3/20 | 0.35 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3966649 | 1.00 | MAPT (0.52) | MAPTKDM4EALDH1A1POLBANPEP | |
| SCHEMBL23532238 | 1.00 | MAPT (0.52) | MAPTKDM4EALDH1A1POLBANPEP | |
| SCHEMBL4254925 | 0.92 | MAPT (0.46) | MAPTKDM4EALDH1A1POLBANPEP | |
| SCHEMBL4209117 | 0.92 | MAPT (0.46) | MAPTKDM4EALDH1A1POLBANPEP | |
| SCHEMBL4252990 | 0.92 | MAPT (0.46) | MAPTKDM4EALDH1A1POLBANPEP | |
| SCHEMBL19473215 | 0.92 | MAPT (0.58) | MAPTKDM4EALDH1A1POLBANPEP | |
| SCHEMBL9119907 | 0.89 | MAPT (0.44) | MAPTKDM4EALDH1A1POLBANPEP | |
| SCHEMBL9119009 | 0.89 | MAPT (0.44) | MAPTKDM4EALDH1A1POLBANPEP | |
| SCHEMBL2243964 | 0.89 | MAPT (0.44) | MAPTKDM4EALDH1A1POLBANPEP | |
| SCHEMBL9282036 | 0.89 | MAPT (0.44) | MAPTKDM4EALDH1A1POLBANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 753 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4211146-B1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | UNIV BAR ILAN (IL) | 2026-05-20 | — | — | EP | claimed |
| WO-2026099626-A1 | METHODS AND SYSTEMS FOR MANUFACTURING RADIOPHARMACEUTICALS | NOVARTIS AG (CH) | 2026-05-15 | — | — | WO | claimed |
| US-12616760-B2 | Synthetic cyclic peptide mimetics | BAR ILAN UNIVERSITY (IL) | 2026-05-05 | — | — | US | claimed |
| EP-4719486-A1 | CONJUGATES AND USES THEREOF | Full-Life Technologies UK Limited (GB) | 2026-04-08 | — | — | EP | claimed |
| EP-4719498-A1 | RADIOLIGANDS FOR TARGETING CELL SURFACE RECEPTORS AND USES THEREOF | Full-Life Technologies UK Limited (GB) | 2026-04-08 | — | — | EP | claimed |
| US-12576168-B2 | Peptide PET/SPECT probes specific to oncoproteins in tumor extracellular matrix | CASE WESTERN RESERVE UNIVERSITY (US) | 2026-03-17 | — | — | US | claimed |
| EP-4705295-A2 | MULTIFUNCTIONAL COMPOUND CORE FOR ACTIVE AGENTS AND USES THEREOF | The University of North Carolina at Chapel Hill (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4694940-A1 | STEAP2-TARGETED COMPOUNDS AND USE THEREOF | Astrazeneca AB (SE) | 2026-02-18 | — | — | EP | claimed |
| US-20260021211-A1 | Dual mode radiotracer and -therapeutics | UNIV MUENCHEN TECH (DE) | 2026-01-22 | — | — | US | claimed |
| US-20250387522-A1 | PSMA TARGETED PET AND FLUORESCENCE IMAGING COMPOUNDS | UNIV CASE WESTERN RESERVE (US) | 2025-12-25 | — | — | US | claimed |
| US-20190175750-A1 | COMPOSITION AND METHOD FOR MODIFYING POLYPEPTIDES | ADVANCED PROTEOME THERAPEUTICS INC. | 2019-06-13 | — | — | US | claimed |
| EP-2453927-B1 | LOADING TECHNIQUE FOR PREPARING RADIONUCLIDE AND IONOPHORE CONTAINING LIPOSOMES IN WHICH THE IONOPHORE IS 2-HYDROXYQUIONOLINE (CARBOSTYRIL) OR STRUCTURALLY RELATED 2-HYDROXYQUINOLINES | UNIV DENMARK TECH DTU (DK) | 2019-05-15 | — | — | EP | claimed |
| EP-2651447-B1 | ENTRAPMENT OF RADIONUCLIDES IN NANOPARTICLE COMPOSITIONS | UNIV DENMARK TECH DTU (DK) | 2018-08-29 | — | — | EP | claimed |
| US-20170296684-A1 | RADIOPHARMACEUTICAL CONJUGATE | UNIVERSITY OF CAPE TOWN (ZA) | 2017-10-19 | — | — | US | claimed |
| US-20160158392-A1 | Entrapment of Radionuclides in Nanoparticle Compositions | RIGSHOSPITALET (DK) | 2016-06-09 | — | — | US | claimed |
| US-9226984-B2 | Entrapment of radionuclides in nanoparticle compositions | Technical University of Denmark and Rigshospitalet (DK) | 2016-01-05 | — | — | US | claimed |
| US-20150202336-A1 | Loading Technique for Preparing Radionuclide Containing Nanoparticles | RIGSHOSPITALET (DK) | 2015-07-23 | — | — | US | claimed |
| US-8920775-B2 | Loading technique for preparing radionuclide containing nanoparticles | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2014-12-30 | — | — | US | claimed |
| US-20130251630-A1 | Entrapment of Radionuclides in Nanoparticle Compositions | RIGSHOSPITALET (DK) | 2013-09-26 | — | — | US | claimed |
| US-20120213698-A1 | LOADING TECHNIQUE FOR PREPARING RADIONUCLIDE CONTAINING NANOPARTICLES | RIGSHOSPITALET (DK) | 2012-08-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616760-B2 | Synthetic cyclic peptide mimetics | TPX2, IAPP, HAX1 | MAPT 1283/4885KDM4E 2888/4885ALDH1A1 4698/4885 |
| US-20150202336-A1 | Loading Technique for Preparing Radionuclide Containing Nanoparticles | LIPG, NPC1L1, CD47 | MAPT 4367/4885KDM4E 2122/4885ALDH1A1 4468/4885 |
| US-12576168-B2 | Peptide PET/SPECT probes specific to oncoproteins in tumor extracellular matrix | FN1, INHA, EDNRB | MAPT 2982/4885KDM4E 2560/4885ALDH1A1 4553/4885 |
| US-20250387522-A1 | PSMA TARGETED PET AND FLUORESCENCE IMAGING COMPOUNDS | PSMA3, PSMA1, PSMA7 | MAPT 670/4885KDM4E 206/4885ALDH1A1 1438/4885 |
| US-20260021211-A1 | Dual mode radiotracer and -therapeutics | FOLH1, SLC19A1, KLK3 | MAPT 3073/4885KDM4E 3927/4885ALDH1A1 2663/4885 |
| US-20190175750-A1 | COMPOSITION AND METHOD FOR MODIFYING POLYPEPTIDES | PTMS, SRMS, ACP1 | MAPT 592/4885KDM4E 3594/4885ALDH1A1 3789/4885 |
| US-20120213698-A1 | LOADING TECHNIQUE FOR PREPARING RADIONUCLIDE CONTAINING NANOPARTICLES | LIPG, NPC1L1, CD47 | MAPT 4367/4885KDM4E 2122/4885ALDH1A1 4468/4885 |
| US-20170296684-A1 | RADIOPHARMACEUTICAL CONJUGATE | FOLH1, EPRS1, FOLR1 | MAPT 3460/4885KDM4E 2174/4885ALDH1A1 1889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.